D-0166-2020 Class III Ongoing
FDA drug recall D-0166-2020 was initiated by AuroMedics Pharma LLC on Sep 23, 2019 and is designated Class III. Reason for recall: CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty. The recall status is ongoing. Affected quantity: 69696 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 6, 2019
- Initiation Date
- Sep 23, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 69696 bottles
Product description
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
Reason for recall
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
Distribution pattern
Nationwide within the United States
Code information
Lot #: NBSB19001DA3, Exp. date 02/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0166-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026